We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
-5.88%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$72.5M
AUM Growth
+$2.3M
Cap. Flow
+$515K
Cap. Flow %
0.71%
Top 10 Hldgs %
42.25%
Holding
101
New
4
Increased
56
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$346K
2
LLY icon
Eli Lilly
LLY
+$273K
3
WDAY icon
Workday
WDAY
+$223K
4
COST icon
Costco
COST
+$205K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$198K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$365K
2
UNP icon
Union Pacific
UNP
+$246K
3
COHR icon
Coherent
COHR
+$235K
4
FDX icon
FedEx
FDX
+$232K
5
ENB icon
Enbridge
ENB
+$214K

Sector Composition

Rank Sector Weight
1 Technology 43.31%
2 Healthcare 15.22%
3 Consumer Discretionary 9.06%
4 Financials 6.72%
5 Communication Services 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$9.91M 13.66%
71,711
-316
-0.4% -$49.6K
AIVI icon
2
WisdomTree International AI Enhanced Value Fund
AIVI
$61.7M
$6.09M 8.4%
+200
New +$6.95K
NVDA icon
3
NVIDIA
NVDA
$4.86T
$3.03M 4.18%
249,720
+1,450
+0.6% +$22.9K
FTNT icon
4
Fortinet
FTNT
$119B
$2.82M 3.89%
57,420
-345
-0.6% -$18.7K
AMD icon
5
Advanced Micro Devices
AMD
$776B
$2.43M 3.35%
38,365
– –
QCOM icon
6
Qualcomm
QCOM
$155B
$1.35M 1.86%
11,935
+803
+7% +$110K
LLY icon
7
Eli Lilly
LLY
$1.02T
$1.28M 1.77%
3,973
+861
+28% +$273K
ABBV icon
8
AbbVie
ABBV
$443B
$1.28M 1.77%
9,547
+47
+0.5% +$6.74K
PANW icon
9
Palo Alto Networks
PANW
$270B
$1.24M 1.71%
15,120
– –
MSFT icon
10
Microsoft
MSFT
$3.45T
$1.21M 1.66%
5,176
+143
+3% +$37.8K
HON icon
11
Honeywell
HON
$77B
$1.19M 1.64%
7,537
+75
+1% +$13.1K
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$4.36T
$1.09M 1.51%
11,425
+485
+4% +$53.8K
BMY icon
13
Bristol-Myers Squibb
BMY
$133B
$1.09M 1.5%
15,336
+80
+0.5% +$5.8K
HD icon
14
Home Depot
HD
$331B
$1.07M 1.48%
3,889
+105
+3% +$31K
META icon
15
Meta Platforms (Facebook)
META
$1.42T
$1.06M 1.47%
7,843
-160
-2% -$25.9K
UNH icon
16
UnitedHealth
UNH
$376B
$1.06M 1.46%
2,103
+142
+7% +$74.7K
JPM icon
17
JPMorgan Chase
JPM
$935B
$957K 1.32%
9,167
+159
+2% +$18.2K
PYPL icon
18
PayPal
PYPL
$48.9B
$950K 1.31%
11,040
-80
-0.7% -$7.09K
ABT icon
19
Abbott
ABT
$183B
$867K 1.2%
8,963
+308
+4% +$32.8K
CRM icon
20
Salesforce
CRM
$151B
$800K 1.1%
5,563
+190
+4% +$32.2K
GOOG icon
21
Alphabet (Google) Class C
GOOG
$4.36T
$761K 1.05%
7,920
– –
AXP icon
22
American Express
AXP
$227B
$755K 1.04%
5,599
+448
+9% +$67.8K
MCD icon
23
McDonald's
MCD
$192B
$748K 1.03%
3,242
+3
+0.1% +$767
MA icon
24
Mastercard
MA
$502B
$733K 1.01%
2,578
-55
-2% -$18.2K
RETA
25
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$707K 0.97%
28,141
– –
1
2 3 4 5

Similar funds

VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
CMBA
C.M. Bidwell & Associates Honolulu, Hawaii $214M AUM 18.82% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return

KRS Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, KRS Capital Management held 101 positions worth $72.5M, up 3.3% from $70.2M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

KRS Capital Management's Q3 2022 filing shows 4 new, 56 increased, 16 reduced and 6 closed positions. Its largest new stake was Pfizer: 7,115 shares worth $311K. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $365K.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 48% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • KRS Capital Management's largest Q3 2022 buy was Pfizer: 7,115 shares worth $311K.
  • KRS Capital Management added most to Eli Lilly in Q3 2022, an estimated $273K increase.
  • KRS Capital Management's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $365K.
  • KRS Capital Management fully exited Union Pacific in Q3 2022, selling an estimated $246K.
  • KRS Capital Management's ten largest holdings make up 42% of its $72.5M portfolio in Q3 2022.
  • KRS Capital Management opened 4 new positions and closed 6 in Q3 2022.
  • KRS Capital Management's portfolio value rose 3.3% quarter-over-quarter to $72.5M.

Based on KRS Capital Management's 13F filing for Q3 2022, filed 21 Oct 2022.